Taiflex Scientific Co Ltd (8039)

Taiwan


	Symbol		Exchange		Currency
	8039		Taiwan		TWD	Delayed
	KIFtmc1		TAIFEX		TWD	Delayed

Currency in TWD

Disclaimer

61.20

+0.20(+0.33%)

Closed04/10

Fair Value

Day's Range

61.00

63.90

52 wk Range

40.55

73.40

8039 Income Statement

Featured here, the Income Statement (earnings report) for Taiflex Scientific Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

7,583.65

8,766.32

9,405

8,721.88

8,150.52

Total Revenues Growth

-21.36%

+15.59%

+7.29%

-7.26%

-6.55%

Cost Of Revenues

5,844.52

6,687.75

7,206.36

6,643.01

6,359.01

Gross Profit

1,739.14

2,078.57

2,198.64

2,078.86

1,791.51

Gross Profit Growth

-12.74%

+19.52%

+5.78%

-5.45%

-13.82%

Gross Profit Margin %

22.93%

23.71%

23.38%

23.84%

21.98%

Other Operating Expenses, Total

1,001.02

1,035.69

1,249.84

1,430.78

1,303.91

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.25%	+3.46%	+20.68%	+14.48%	-8.87%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	284.49	281.36	323.22	400.59	366.52
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	716.53	754.33	926.62	1,030.19	937.39
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

738.12

1,042.89

948.81

648.08

487.6

Operating Income Growth

-23.82%

+41.29%

-9.02%

-31.7%

-24.76%

EBIT Margin %

9.73%

11.9%

10.09%

7.43%

5.98%

Net Interest Expenses

-4.76

-12.88

-15.43

-19.93

-4.89

Net Interest Expenses Growth

+83.63%

-170.91%

-19.76%

-29.19%

+75.48%

Interest Expense, Total

-19.72

-20.76

-20.8

-35.21

-32.46

Interest And Investment Income

14.96

7.88

5.37

15.28

27.57

Other Non Operating Expenses, Total

-32.91

-73.36

9.64

208.89

-0.89

EBT, Excl. Unusual Items

700.46

956.64

943.02

837.04

481.82

Gain (Loss) On Sale Of Assets

-27.22

33.16

-6.69

0.43

-0.31

Other Unusual Items, Total

119.21

-24

2.88

-

-

EBT, Incl. Unusual Items

792.45

965.8

940.81

877.31

482.32

EBT, Incl. Unusual Items Growth

-8.76%

+21.87%

-2.59%

-6.75%

-45.02%

EBT, Incl. Unusual Items Margin

10.45

11.02

10

10.06

5.92

Income Tax Expense

174.17

181.44

195.95

185.6

121.6

Net Income to Company

618.28

784.35

744.86

691.71

360.72

Minority Interest

12.4

-11.49

-10.21

8.77

62.25

Net Income

630.68

772.86

734.65

700.48

422.97

Net Income Growth

-6.19%

+22.54%

-4.94%

-4.65%

-39.62%

Net Income Margin %

8.32%

8.82%

7.81%

8.03%

5.19%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

630.68

772.86

734.65

700.48

422.97

Basic EPS - Continuing Operations

2.88

3.53

3.36

3.2

1.93

Basic EPS - Continuing Operations Growth

-6.21%

+22.54%

-4.94%

-4.65%

-39.62%

Diluted EPS - Continuing Operations

2.87

3.51

2.85

2.74

1.65

Diluted EPS - Continuing Operations Growth

-5.66%

+22.34%

-18.84%

-3.74%

-39.77%

Basic Weighted Average Shares Outstanding

218.74

218.74

218.74

218.74

218.74

Diluted Weighted Average Shares Outstanding

220.14

220.18

258.41

260.78

264.98

Dividend Per Share

2.39

2.39

2.39

2.39

0.88

Dividend Per Share Growth

0%

0%

0%

0%

-63.21%

EBITDA

1,049.64

1,336.27

1,301.96

1,034.88

896.01

EBITDA Growth

-16.84%

+27.31%

-2.57%

-20.51%

-13.42%

EBITDA Margin %

13.84%

15.24%

13.84%

11.87%

10.99%

EBIT

738.12

1,042.89

948.81

648.08